NIAID supports research in the following areas to improve TB diagnosis, control, and prevention.
Read about TB Basic Research.
Read about TB Prevention: Vaccine Development.
Read about TB Diagnostic Research.
Support research, including the development of new molecular tools, to assess the factors influencing the occurrence, distribution, and transmission of drug-sensitive and drug-resistant Mycobacterium tuberculosis (Mtb) strains.
Support research to improve animal models of infection and disease for use in the study of virulence and pathogenicity of drug-sensitive and drug-resistant Mtb and for the evaluation of candidate anti-TB therapies and vaccines.
Read about Advances in TB Treatment.
Foster and support clinical research to evaluate and improve effectiveness of regimens for treatment and prophylaxis of Mtb, especially MDR TB, in the setting of HIV co-infection.
Accelerate development and commercialization of candidate TB treatments identified through NIAID TB drug screening contracts or otherwise developed at the National Institutes of Health, universities, and nonprofit laboratories.
Promote training to increase the number, and improve the skills, of TB basic and clinical researchers. Read about TB Research Training.
back to top
Last Updated February 22, 2007